Wimmer Associates 1’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.49M | Sell |
10,175
-74
| -0.7% | -$17.2K | 1.22% | 21 |
|
|
2025
Q4 | $2.12M | Sell |
10,249
-179
| -2% | -$35.4K | 0.99% | 29 |
|
|
2025
Q3 | $1.93M | Hold |
10,428
| – | – | 0.93% | 29 |
|
|
2025
Q2 | $1.59M | Sell |
10,428
-155
| -1% | -$23.8K | 0.81% | 31 |
|
|
2025
Q1 | $1.57M | Sell |
10,583
-137
| -1% | -$21.4K | 0.83% | 31 |
|
|
2024
Q4 | $1.55M | Sell |
10,720
-10
| -0.1% | -$1.55K | 0.77% | 31 |
|
|
2024
Q3 | $1.74M | Hold |
10,730
| – | – | 0.85% | 30 |
|
|
2024
Q2 | $1.57M | Sell |
10,730
-222
| -2% | -$33K | 0.8% | 32 |
|
|
2024
Q1 | $1.73M | Sell |
10,952
-106
| -1% | -$16.9K | 0.91% | 31 |
|
|
2023
Q4 | $1.73M | Buy |
11,058
+110
| +1% | +$16.9K | 0.98% | 31 |
|
|
2023
Q3 | $1.71M | Sell |
10,948
-664
| -6% | -$110K | 1.06% | 30 |
|
|
2023
Q2 | $1.92M | Sell |
11,612
-80
| -0.7% | -$12.9K | 1.16% | 27 |
|
|
2023
Q1 | $1.87M | Sell |
11,692
-159
| -1% | -$25.7K | 1.19% | 27 |
|
|
2022
Q4 | $2.09M | Sell |
11,851
-45
| -0.4% | -$7.77K | 1.38% | 25 |
|
|
2022
Q3 | $2.07M | Sell |
11,896
-170
| -1% | -$28.8K | 1.37% | 25 |
|
|
2022
Q2 | $2.14M | Sell |
12,066
-39
| -0.3% | -$6.95K | 1.4% | 25 |
|
|
2022
Q1 | $2.15M | Sell |
12,105
-70
| -0.6% | -$11.9K | 1.19% | 27 |
|
|
2021
Q4 | $2.08M | Sell |
12,175
-191
| -2% | -$31.3K | 1.12% | 29 |
|
|
2021
Q3 | $2M | Buy |
12,366
+44
| +0.4% | +$7.51K | 1.18% | 25 |
|
|
2021
Q2 | $2.03M | Sell |
12,322
-153
| -1% | -$25.3K | 1.19% | 26 |
|
|
2021
Q1 | $2.05M | Sell |
12,475
-747
| -6% | -$121K | 1.12% | 26 |
|
|
2020
Q4 | $2.08M | Buy |
13,222
+329
| +3% | +$48.5K | 1.24% | 22 |
|
|
2020
Q3 | $1.92M | Buy |
12,893
+410
| +3% | +$60.7K | 1.29% | 27 |
|
|
2020
Q2 | $1.85M | Sell |
12,483
-329
| -3% | -$47.9K | 1.44% | 23 |
|
|
2020
Q1 | $1.68M | Buy |
12,812
+1,058
| +9% | +$150K | 1.56% | 23 |
|
|
2019
Q4 | $1.72M | Sell |
11,754
-255
| -2% | -$34.6K | 1.37% | 26 |
|
|
2019
Q3 | $1.55M | Sell |
12,009
-2,294
| -16% | -$302K | 1.36% | 28 |
|
|
2019
Q2 | $1.99M | Sell |
14,303
-65
| -0.5% | -$9K | 1.74% | 21 |
|
|
2019
Q1 | $2.01M | Sell |
14,368
-464
| -3% | -$62.2K | 1.78% | 19 |
|
|
2018
Q4 | $1.91M | Sell |
14,832
-2,083
| -12% | -$291K | 1.9% | 16 |
|
|
2018
Q3 | $2.34M | Sell |
16,915
-83
| -0.5% | -$11K | 1.94% | 13 |
|
|
2018
Q2 | $2.06M | Buy |
16,998
+50
| +0.3% | +$6.24K | 1.84% | 16 |
|
|
2018
Q1 | $2.17M | Sell |
16,948
-259
| -2% | -$35K | 1.91% | 15 |
|
|
2017
Q4 | $2.4M | Sell |
17,207
-79
| -0.5% | -$11K | 2.16% | 10 |
|
|
2017
Q3 | $2.25M | Sell |
17,286
-1,694
| -9% | -$225K | 2.07% | 10 |
|
|
2017
Q2 | $2.51M | Sell |
18,980
-889
| -4% | -$113K | 2.31% | 8 |
|
|
2017
Q1 | $2.48M | Sell |
19,869
-1,554
| -7% | -$186K | 2.31% | 8 |
|
|
2016
Q4 | $2.47M | Sell |
21,423
-598
| -3% | -$69.1K | 2.29% | 8 |
|
|
2016
Q3 | $2.6M | Sell |
22,021
-961
| -4% | -$117K | 2.34% | 7 |
|
|
2016
Q2 | $2.79M | Sell |
22,982
-683
| -3% | -$77.6K | 2.49% | 5 |
|
|
2016
Q1 | $2.56M | Buy |
23,665
+2,317
| +11% | +$240K | 2.35% | 7 |
|
|
2015
Q4 | $2.19M | Buy |
+21,348
| New | +$2.15M | 2.3% | 10 |
|
Other funds holding JNJ
VCM
VPM
Wimmer Associates 1's JNJ Position: Q1 2026 in Review
Wimmer Associates 1 reduced its Johnson & Johnson (JNJ) stake by 0.72% in Q1 2026, selling an estimated $17.2K and leaving 10,175 shares worth $2.49M. The position accounts for 1.22% of the portfolio, ranked #21.
Wimmer Associates 1 first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.79M in Q2 2016. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Wimmer Associates 1 held 10,175 shares of Johnson & Johnson worth $2.49M as of Q1 2026.
- Wimmer Associates 1 sold 74 Johnson & Johnson shares in Q1 2026, an estimated $17.2K.
- Johnson & Johnson made up 1.22% of Wimmer Associates 1's portfolio in Q1 2026, its #21 holding.
- Wimmer Associates 1 first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
- Wimmer Associates 1's Johnson & Johnson position peaked at $2.79M in Q2 2016.
- 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Wimmer Associates 1's 13F filing for Q1 2026, filed 15 May 2026.